OncoMark Articles in Company News Section. http://www.oncomark.com SpeckCMS en 1440 Sun, 25 Jun 2017 01:01:04 May 2017: OncoMark Researchers Shed Light on the Discovery and Validation of Master Transcriptional Regulators in Cancer http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=812E9400-60F5-4EB0-8457ACBD9ACF352B 812E9400-60F5-4EB0-8457ACBD9ACF352B OncoMark researchers have recently had a review published in the American Association for Cancer Research (AACR) journal, Cancer Research, describing how the reverse engineering of transcriptional networks using gene expression data enables the identification of genes that underpin the development and progression of different cancers. Thu, 25 May 2017 12:11:15 May 2017: OncoMark looking for an applicant for a Marie Sklodowska-Curie Enterprise Fellowship http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=2D0AFAAA-0DAA-4BCF-9E050F372AFB11E1 2D0AFAAA-0DAA-4BCF-9E050F372AFB11E1 OncoMark are actively looking for a talented researcher to apply for a Marie Curie Individual Fellowship under the MSCA Enterprise Call. We would welcome researchers and / or research proposals across several areas of cancer research including breast cancer, colorectal cancer, prostate cancer and melanoma. Mon, 15 May 2017 14:14:27 March 2017: Prof. William Gallagher Awarded Prestigious Medal for Outstanding Contribution to Irish Cancer Research http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=D0122306-0D07-42E6-9C0B48393D77B443 D0122306-0D07-42E6-9C0B48393D77B443 Congratulations to Professor William Gallagher, who was the inaugural recipient of the Irish Association of Cancer Research (IACR) Cancer Research Medal at the annual IACR Conference held in Kilkenny on 22nd-24th February 2017. This prestigious award recognises his outstanding contribution to the cancer research community in Ireland throughout his career. Fri, 21 Apr 2017 08:53:26 Feb 2017: OncoMark Secures €2.1 Million Investment to Commercialise New Diagnostic Test for Breast Cancer http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=3E5F25A8-B244-46F2-A862608220D4B953 3E5F25A8-B244-46F2-A862608220D4B953 OncoMasTR test to launch in 2018 and will reduce the number of patients receiving unnecessary chemotherapy Wed, 15 Feb 2017 08:24:34 Oct 2016: OncoMark wins award at industry event in Brussels! http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=F5EFF69C-D1D9-6D29-F8B107983CED0781 F5EFF69C-D1D9-6D29-F8B107983CED0781  Mr Des O'Leary, OncoMark's CEO, pitched to an audience of CEOs from more than 400 SMEs from around Europe. Mon, 24 Oct 2016 10:54:17 April 2016 - OncoMasTR assay for breast cancer featured in the Medical Independent http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C8FDF5F-B28F-E78B-1ECDB7227CD7C1C4 4C8FDF5F-B28F-E78B-1ECDB7227CD7C1C4 Prof. William Gallagher describes the OncoMasTR assay for breast cancer in the Medical Independent Wed, 21 Sep 2016 12:55:18 April 2016 - OncoMasTR assay for breast cancer featured in the Irish Examiner http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C877FD0-E8D8-28E5-F994065A0EEFAAF7 4C877FD0-E8D8-28E5-F994065A0EEFAAF7 The Irish Examiner interviews OncoMark's Chief Scientific Officer about the OncoMasTR assay for breast cancer Wed, 21 Sep 2016 12:43:03 November 2015 - OncoMark featured in The Sunday Times http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C7C0C0E-CC18-33E5-1BC796C46A895A8E 4C7C0C0E-CC18-33E5-1BC796C46A895A8E OncoMark's CEO Mr Desmond O'Leary was interviewed for the Sunday Times Wed, 21 Sep 2016 12:29:19 September 2015 - OncoMark profiled in 'Ones to Watch' article in Business & Finance http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C76332C-F3A0-EA7E-753F476752633307 4C76332C-F3A0-EA7E-753F476752633307 OncoMark have been profiled in the 'Ones to Watch' feature in Business & Finance Wed, 21 Sep 2016 12:22:45 September 2015 - OncoMark are awarded €2.7 million by the European Commission to develop a diagnostic assay for breast cancer http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=AD5EE424-B0AC-14DA-54DB9BD828522D6B AD5EE424-B0AC-14DA-54DB9BD828522D6B  OncoMark are pleased to announce they have been awarded €2.7 million by the European Commission, for the commercial development of a new Diagnostic test for breast cancer patients. Tue, 08 Sep 2015 15:35:21